Ticlopidine Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00208 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 70 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid arthritis | KG + DL |
| 2 | female breast carcinoma | KG + DL |
| 3 | obsolete familial combined hyperlipidemia | KG + DL |
| 4 | homozygous familial hypercholesterolemia | KG + DL |
| 5 | hypoalphalipoproteinemia | KG + DL |
| 6 | brachydactyly-syndactyly syndrome | KG + DL |
| 7 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 8 | HIV infectious disease | KG + DL |
| 9 | leprosy | KG + DL |
| 10 | multiple endocrine neoplasia | KG + DL |
| 11 | cholecystolithiasis | KG + DL |
| 12 | obsolete hyperuricemia (disease) | KG + DL |
| 13 | pulmonary hypertension | KG + DL |
| 14 | oral candidiasis | KG + DL |
| 15 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 16 | feline acquired immunodeficiency syndrome | KG + DL |
| 17 | simian immunodeficiency virus infection | KG + DL |
| 18 | osteoradionecrosis of the mandible | KG + DL |
| 19 | commissural lip fistula | KG + DL |
| 20 | burning mouth syndrome | KG + DL |
| 21 | oral leukoedema | KG + DL |
| 22 | methemoglobinemia | KG + DL |
| 23 | kyphoscoliotic heart disease | KG + DL |
| 24 | methemoglobinemia, alpha type | KG + DL |
| 25 | headache disorder | KG + DL |
| 26 | gout | KG + DL |
| 27 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 28 | trigeminal autonomic cephalalgia | KG + DL |
| 29 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 30 | methemoglobin reductase deficiency | KG + DL |
| 31 | scalp dermatosis | KG + DL |
| 32 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 33 | nipple carcinoma | KG + DL |
| 34 | paratenonitis | KG + DL |
| 35 | calcific tendinitis | KG + DL |
| 36 | dermatofibrosarcoma protuberans | KG + DL |
| 37 | Lesch-Nyhan syndrome | KG + DL |
| 38 | breast carcinoma by gene expression profile | KG + DL |
| 39 | diabetic nephropathy | KG + DL |
| 40 | motor nerve neuritis | KG + DL |
| 41 | bilateral breast carcinoma | KG + DL |
| 42 | Plasmodium falciparum malaria | KG + DL |
| 43 | fibroma of prostate | KG + DL |
| 44 | estrogen-receptor negative breast cancer | KG + DL |
| 45 | Ehrlich tumor carcinoma | KG + DL |
| 46 | hormone-resistant breast carcinoma | KG + DL |
| 47 | estrogen-receptor positive breast cancer | KG + DL |
| 48 | benign reproductive system neoplasm | KG + DL |
| 49 | sickle cell-hemoglobin E disease syndrome | KG + DL |
| 50 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
(Showing top 50 of 70 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.